rdf:type |
|
lifeskim:mentions |
umls-concept:C0009429,
umls-concept:C0017431,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0205466,
umls-concept:C0524910,
umls-concept:C0556895,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C0907160,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
8
|
pubmed:dateCreated |
2011-7-29
|
pubmed:abstractText |
Sustained virological response (SVR) rates in patients with hepatitis C are heterogeneous and are influenced by a wide range of host and viral factors.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1573-2568
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2449-55
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21706207-Adolescent,
pubmed-meshheading:21706207-Adult,
pubmed-meshheading:21706207-Age Factors,
pubmed-meshheading:21706207-Aged,
pubmed-meshheading:21706207-Alanine Transaminase,
pubmed-meshheading:21706207-Alcohol Drinking,
pubmed-meshheading:21706207-Antiviral Agents,
pubmed-meshheading:21706207-Body Mass Index,
pubmed-meshheading:21706207-Drug Therapy, Combination,
pubmed-meshheading:21706207-Female,
pubmed-meshheading:21706207-Hepacivirus,
pubmed-meshheading:21706207-Hepatitis C, Chronic,
pubmed-meshheading:21706207-Humans,
pubmed-meshheading:21706207-Interferon-alpha,
pubmed-meshheading:21706207-Liver Cirrhosis,
pubmed-meshheading:21706207-Male,
pubmed-meshheading:21706207-Middle Aged,
pubmed-meshheading:21706207-Polyethylene Glycols,
pubmed-meshheading:21706207-RNA, Viral,
pubmed-meshheading:21706207-Recombinant Proteins,
pubmed-meshheading:21706207-Retrospective Studies,
pubmed-meshheading:21706207-Ribavirin,
pubmed-meshheading:21706207-Treatment Outcome,
pubmed-meshheading:21706207-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C.
|
pubmed:affiliation |
Department of Hepatology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
|
pubmed:publicationType |
Journal Article
|